Anish Suri Cue Biopharma, Inc. (CUE) insider trading activity

Anish Suri is PRESIDENT AND CSO of Cue Biopharma, Inc.. Currently has a direct ownership of 135,638 shares of CUE, which is worth approximately $218,377. The most recent transaction as insider was on Aug 25, 2023, when has been sold 4,000 shares (Common Stock) at a price of $2.76 per share, resulting in proceeds of $11,040. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 136K

0% 3M change

0% 12M change

Total Value Held $218,377

Anish Suri Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 25 2023	BUY Open market or private purchase	$11,040 $2.76 p/Share	4,000 Added 2.86%	135,638 Common Stock
Mar 31 2022	SELL Payment of exercise price or tax liability	$34,492 $4.88 p/Share	7,068 Reduced 6.38%	103,638 Common Stock
Mar 31 2022	BUY Exercise of conversion of derivative security	-	16,668 Added 13.09%	110,706 Common Stock
Nov 15 2021	SELL Open market or private sale	$144,400 $18.05 p/Share	8,000 Reduced 7.84%	94,038 Common Stock
Nov 15 2021	BUY Exercise of conversion of derivative security	$66,080 $8.26 p/Share	8,000 Added 7.27%	102,038 Common Stock
Nov 11 2021	SELL Open market or private sale	$301,400 $15.07 p/Share	20,000 Reduced 17.54%	94,038 Common Stock
Nov 11 2021	BUY Exercise of conversion of derivative security	$128,400 $6.42 p/Share	20,000 Added 14.92%	114,038 Common Stock
Oct 06 2021	SELL Payment of exercise price or tax liability	$183,318 $12.97 p/Share	14,134 Reduced 13.07%	94,038 Common Stock
Oct 03 2021	BUY Exercise of conversion of derivative security	-	33,334 Added 23.56%	108,172 Common Stock
Sep 23 2021	SELL Open market or private sale	$304,600 $15.23 p/Share	20,000 Reduced 21.09%	74,838 Common Stock
Sep 23 2021	BUY Exercise of conversion of derivative security	$128,400 $6.42 p/Share	20,000 Added 17.42%	94,838 Common Stock
Oct 05 2020	SELL Payment of exercise price or tax liability	$159,740 $16.3 p/Share	9,800 Reduced 14.43%	58,091 Common Stock
Oct 03 2020	BUY Exercise of conversion of derivative security	-	33,333 Added 32.93%	67,891 Common Stock

Anish Suri

PRESIDENT AND CSO

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CUE shares.

Notify only if

Value

Insider Trading

Get notified when an Cue Biopharma, Inc. insider buys or sells CUE shares.

Notify only if

Operation

Value

Type

News

Receive news related to Cue Biopharma, Inc.

Track Activities on CUE

Account